(Q83742119)
Statements
JSH-23 targets nuclear factor-kappa B and reverses various deficits in experimental diabetic neuropathy: effect on neuroinflammation and antioxidant defence (English)
A Kumar
G Negi
scientific article published on 01 August 2011